Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPLEX in Myotonic Dystrophy Type 1
NCT00577577Phase 2Completed
- Sponsor
- Insmed Incorporated
- Start
- Dec 2007
- Primary completion
- Dec 2008
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mecasermin rinfabate in myotonic dystrophy type 1 (DM1), sponsored by Insmed Incorporated. Started Dec 2007; status: completed.
02
Drugs
mecasermin rinfabate
03
Conditions
myotonic dystrophy type 1 (DM1)
Beyond the preview
Go deeper on NCT00577577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577577.